196 related articles for article (PubMed ID: 34960750)
1. Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus.
Ravlić S; Brgles M; Hiršl L; Jonjić S; Halassy B
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960750
[TBL] [Abstract][Full Text] [Related]
2. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
[TBL] [Abstract][Full Text] [Related]
3. Potential Application of TALENs against Murine Cytomegalovirus Latent Infections.
Chen SJ; Chen YC
Viruses; 2019 May; 11(5):. PubMed ID: 31058862
[TBL] [Abstract][Full Text] [Related]
4. The Human Cytomegalovirus Chemokine vCXCL-1 Modulates Normal Dissemination Kinetics of Murine Cytomegalovirus
Jackson JW; Hancock TJ; LaPrade E; Dogra P; Gann ER; Masi TJ; Panchanathan R; Miller WE; Wilhelm SW; Sparer TE
mBio; 2019 Jun; 10(3):. PubMed ID: 31239384
[TBL] [Abstract][Full Text] [Related]
5. Enhancer requirement for murine cytomegalovirus growth and genetic complementation by the human cytomegalovirus enhancer.
Angulo A; Messerle M; Koszinowski UH; Ghazal P
J Virol; 1998 Nov; 72(11):8502-9. PubMed ID: 9765387
[TBL] [Abstract][Full Text] [Related]
6. Cellular reservoirs of latent cytomegaloviruses.
Reddehase MJ; Lemmermann NAW
Med Microbiol Immunol; 2019 Aug; 208(3-4):391-403. PubMed ID: 31011793
[TBL] [Abstract][Full Text] [Related]
7. Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation.
Farrell HE; Bruce K; Lawler C; Oliveira M; Cardin R; Davis-Poynter N; Stevenson PG
mBio; 2017 Oct; 8(5):. PubMed ID: 28974616
[TBL] [Abstract][Full Text] [Related]
8. Atomic structures and deletion mutant reveal different capsid-binding patterns and functional significance of tegument protein pp150 in murine and human cytomegaloviruses with implications for therapeutic development.
Liu W; Dai X; Jih J; Chan K; Trang P; Yu X; Balogun R; Mei Y; Liu F; Zhou ZH
PLoS Pathog; 2019 Feb; 15(2):e1007615. PubMed ID: 30779794
[TBL] [Abstract][Full Text] [Related]
9. Characterization of murine cytomegalovirus infection and induction of calcification in Murine Aortic Vascular Smooth Muscle Cells (MOVAS).
Bonavita CM; White TM; Stanfield BA; Cardin RD
J Virol Methods; 2021 Nov; 297():114270. PubMed ID: 34461152
[TBL] [Abstract][Full Text] [Related]
10. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
Neyts J; De Clercq E
Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
[TBL] [Abstract][Full Text] [Related]
11. Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.
Wilski NA; Del Casale C; Purwin TJ; Aplin AE; Snyder CM
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375579
[TBL] [Abstract][Full Text] [Related]
12. Development and clinical application of a fully controlled quantitative PCR assay for cell-free cytomegalovirus in human plasma.
Preiser W; Brink NS; Ayliffe U; Peggs KS; Mackinnon S; Tedder RS; Garson JA
J Clin Virol; 2003 Jan; 26(1):49-59. PubMed ID: 12589834
[TBL] [Abstract][Full Text] [Related]
13. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of human cytomegalovirus persistence and latency.
Jarvis MA; Nelson JA
Front Biosci; 2002 Jun; 7():d1575-82. PubMed ID: 12045013
[TBL] [Abstract][Full Text] [Related]
15. Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
Scott GM; Ng HL; Morton CJ; Parker MW; Rawlinson WD
J Gen Virol; 2005 Aug; 86(Pt 8):2141-2151. PubMed ID: 16033961
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.
Chien H; Alston CI; Dix RD
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976680
[TBL] [Abstract][Full Text] [Related]
17. An adjuvanted inactivated murine cytomegalovirus (MCMV) vaccine induces potent and long-term protective immunity against a lethal challenge with virulent MCMV.
Wang H; Yao Y; Huang C; Fu X; Chen Q; Zhang H; Chen J; Fang F; Xie Z; Chen Z
BMC Infect Dis; 2014 Apr; 14():195. PubMed ID: 24720840
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus Infection and Inflammation in Developing Brain.
Krstanović F; Britt WJ; Jonjić S; Brizić I
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200083
[TBL] [Abstract][Full Text] [Related]
19. Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.
Farrell HE; Davis-Poynter N; Bruce K; Lawler C; Dolken L; Mach M; Stevenson PG
J Virol; 2015 Jul; 89(14):7147-58. PubMed ID: 25926638
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
